These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27518323)
41. Insights into direct nose to brain delivery: current status and future perspective. Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636 [TBL] [Abstract][Full Text] [Related]
42. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study. Pokharkar V; Patil-Gadhe A; Palla P Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752 [TBL] [Abstract][Full Text] [Related]
43. Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery. El Taweel MM; Aboul-Einien MH; Kassem MA; Elkasabgy NA Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834242 [TBL] [Abstract][Full Text] [Related]
44. Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats. Wang C; Quan LH; Guo Y; Liu CY; Liao YH Int J Pharm; 2007 Jun; 337(1-2):155-60. PubMed ID: 17267150 [TBL] [Abstract][Full Text] [Related]
45. Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data. Bergström M; Yates R; Wall A; Kågedal M; Syvänen S; Långström B J Pharmacokinet Pharmacodyn; 2006 Feb; 33(1):75-91. PubMed ID: 16402287 [TBL] [Abstract][Full Text] [Related]
46. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501 [TBL] [Abstract][Full Text] [Related]
47. Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway. Mustafa G; Alrohaimi AH; Bhatnagar A; Baboota S; Ali J; Ahuja A Drug Deliv; 2016; 23(3):933-9. PubMed ID: 24959938 [TBL] [Abstract][Full Text] [Related]
48. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494 [TBL] [Abstract][Full Text] [Related]
49. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates. Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237 [TBL] [Abstract][Full Text] [Related]
50. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients]. Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773 [TBL] [Abstract][Full Text] [Related]
51. [Effect of N-acetyl-L-cysteine on bioavailability and brain distribution of curcumin by nasal delivery]. Su WQ; Wei TX; Jing J; Meng ZP; Chen XY; Wu XX; Zhu HX; Fu TM Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2841-2848. PubMed ID: 31359699 [TBL] [Abstract][Full Text] [Related]
52. Microneedle-assisted transdermal delivery of Zolmitriptan: effect of microneedle geometry, in vitro permeation experiments, scaling analyses and numerical simulations. Uppuluri CT; Devineni J; Han T; Nayak A; Nair KJ; Whiteside BR; Das DB; Nalluri BN Drug Dev Ind Pharm; 2017 Aug; 43(8):1292-1303. PubMed ID: 28375038 [TBL] [Abstract][Full Text] [Related]
53. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement. Gera S; Talluri S; Rangaraj N; Sampathi S AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300 [TBL] [Abstract][Full Text] [Related]
54. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain. Ved PM; Kim K Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294 [TBL] [Abstract][Full Text] [Related]
55. Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery. Kanazawa T; Fukuda M; Suzuki N; Suzuki T J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507914 [TBL] [Abstract][Full Text] [Related]
56. Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice. Serralheiro A; Alves G; Fortuna A; Falcão A Int J Pharm; 2015 Jul; 490(1-2):39-46. PubMed ID: 25979854 [TBL] [Abstract][Full Text] [Related]
58. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting. Shah B; Khunt D; Misra M; Padh H Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration. Li N; Je YJ; Yang M; Jiang XH; Ma JH Pharmazie; 2011 May; 66(5):374-7. PubMed ID: 21699072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]